La chaîne d'options affiche les données clés des options sur actions de Vertical Aerospace à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour Vertical Aerospace..

Vertical Aerospace (NYSE:EVTL) Stock, Chaîne d'Options

Vertical Aerospace

Vertical Aerospace Ltd is engaged in making air travel personal, on-demand, and carbon-free. The company is a world-wide aerospace and technology company that is pioneering electric aviation, focused on designing, manufacturing, and selling a zero operating emission eVTOL aircraft for use in the AAM market, using the technology from the aerospace, automotive, and energy industries. The VX4, Vertical's flagship aircraft, is a piloted electric vertical take-off and landing (eVTOL) vehicle capable of carrying four passengers. The Group operates as a single operating segment and one reporting segment, being the development and commercialization of eVTOL technology.

Vertical Aerospace Ltd

Keefe, Bruyette &amp; Woods analyst Christopher Mcgratty maintains Comerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMA#NYSE">CMA</a>) with a Outperform and raises the price target from $69 to $73.

News

Price Target

Analyst Ratings

Keefe, Bruyette & Woods Maintains Outperform on Comerica, Raises Price Target to $73

GigaMedia Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIGM#NASDAQ">GIGM</a>) today announced that the Company has entered into and executed an agreement to purchase a US$1,500,000 principal amount of convertible promissory note (the "Note") issued by Aeolus Robotics Corporation ("Aeolus"), a global company primarily engaged in designing, manufacturing, processing and sales of intellectual robotics.
&nbsp;
The Note, bearing interest at a rate of 4.5% per annum, shall be due in 36 months, and all or a portion of the principal amount under the Note may be convertible at GigaMedia's option upon maturity, upon prepayment, or when certain events occur, into ordinary shares of Aeolus at a price of US$0.02 per share.
&nbsp;
The purchase and sale of the Note exhibits GigaMedia and Aeolus's mutual commitment to a longer-term strategic relationship. GigaMedia continually reviews its investment alternatives and may enter into additional transactions of Aeolus's securities in accordance with applicable laws.

GIGM

GigaMedia Invests $1.5M in Aeolus Robotics Via Convertible Note With 4.5% Interest Over 3 Years

Domino's Pizza (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) reported quarterly earnings of $3.81 per share which missed the analyst consensus estimate of $3.93 by 3.15 percent. This is a 5.46 percent decrease over earnings of $4.03 per share from the same period last year. The company reported quarterly sales of $1.15 billion which beat the analyst consensus estimate of $1.14 billion by 0.13 percent. This is a 4.28 percent increase over sales of $1.10 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

Domino's Pizza Q2 EPS $3.81 Misses $3.93 Estimate, Sales $1.15B Beat $1.14B Estimate

Keefe, Bruyette &amp; Woods analyst Kyle Voigt maintains Charles Schwab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCHW#NYSE">SCHW</a>) with a Outperform and raises the price target from $102 to $108.

SCHW

Keefe, Bruyette & Woods Maintains Outperform on Charles Schwab, Raises Price Target to $108

SQNS

Sequans Adds 1,264 Bitcoin For $150M, Boosts Treasury Holdings To 2,317 BTC

Keefe, Bruyette &amp; Woods analyst Chris O'Cull maintains Chemung Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHMG#NASDAQ">CHMG</a>) with a Market Perform and raises the price target from $55 to $59.

CHMG

Keefe, Bruyette & Woods Maintains Market Perform on Chemung Financial, Raises Price Target to $59

GLDG

GoldMining Taps Copper Surge With Over 1.7 Billion Pounds In Resources Across Americas

The Ether Machine, Inc. ("the Company" or "The Ether Machine"), a newly formed entity enabling public market investors to access Ethereum yield, announced its public launch today through a definitive business combination agreement between The Ether Reserve, LLC and Dynamix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNX#NASDAQ">DYNX</a>). Upon the closing of the business combination, the combined entity will trade on NASDAQ under the ticker symbol "ETHM".
The Ether Machine is building the largest public vehicle for institutional-grade exposure to&nbsp;Ethereum, offering secure, transparent, and compliant access to ETH-denominated yield. As a strategic Ether generation company, it aims to deliver long-term, risk-adjusted returns through staking, restaking, and decentralized finance strategies.

IPOs

DYNX

The Ether Machine to Go Public via Merger With Dynamix, Will Trade on NASDAQ as 'ETHM'

Priscilla Chan says advanced GPU clusters aren't just a lure for Silicon Valley, biologists want them, too.
What Happened: Speaking on Ashlee Vance's Core Memory <a href="https://www.youtube.com/watch?v=F1-MFboIASg">podcast</a>, the Chan Zuckerberg Initiative (CZI) co‑founder said the nonprofit now fields roughly 1,000 high‑end graphics chips and is buying more so researchers can do the work they want to do, even if CZI cannot match Big Tech salaries.
Her remarks land as husband Mark Zuckerberg's new Superintelligence Labs woos AI engineers with eight‑figure packages and a pledge to control 1.3 million GPUs by year‑end.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Priscilla Chan&#039;s Multi-Billion Dollar Quest to End Disease" width="500" height="281" src="https://www.youtube.com/embed/F1-MFboIASg?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
"The other thing researchers really care about is access to GPUs," Chan said. "You're not going to make the most of someone if you don't actually have the GPUs for them to work from." CZI's cluster sits at about 1,000 GPUs, with plans to keep growing, she added.
See Also: <a href="https://www.benzinga.com/markets/equities/25/07/46511927/dave-portnoys-10-million-elon-musk-bet-pays-off-as-tesla-soars-12-in-two-weeks-thats-a-million-bucks">Dave Portnoy&#8217;s $10 Million Elon Musk Bet Pays Off As Tesla Soars 12% In Two Weeks: &#8216;That&#8217;s A Million Bucks&#8217;</a>
Chan tells candidates, "Come work with us because we're going to have the computing power to support the research that you want to do." Pay, she concedes, is "obviously important," yet "we cannot compete with tech companies on this."
The organization has tightened its focus to a "science‑first philanthropy," devoting its biggest bets to biomedical discovery.
Why It Matters: Meta's CEO has a different magnet and that&#8217;s money. Zuckerberg <a href="https://www.threads.com/@theinformation/post/DMGueMrvzTn?xmt=AQF01JbYaFpSpZjtgyA4hVgBJbrdte7zTgFAD6II1raMTQ">told</a> The Information recently that recruits want "the fewest number of people reporting to me and the most GPUs." Meta will spend up to <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43196266/whats-going-on-with-meta-shares-friday-2">$65 billion this year</a> and expects "over 1.3 million graphics processors" online by December.
Meta last week <a href="https://www.benzinga.com/markets/tech/25/07/46434602/mark-zuckerbergs-meta-poaches-top-openai-researchers-jason-wei-and-hyung-won-chung-for-its-superintelligence-lab-report">hired two top researchers</a> from OpenAI for its ambitious new superintelligence lab. This recruitment comes amid a wave of aggressive AI hiring by the company, which has reportedly offered compensation packages of up to $300 million over four years to lure talent from rivals.
That said, analysts warn that Meta's spree will <a href="https://www.benzinga.com/25/01/43214849/mark-zuckerbergs-65-billion-bet-benefits-nvidia-and-other-ai-players-top-analyst-warns-the-run-will-end-in-a-spectacular-bubble-burst">inflate GPU prices</a> and could crowd out nonprofits unless vendors offer discounted cycles.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/07/46513294/nvidia-ceo-jensen-huang-says-hed-ditch-software-for-physical-sciences-if-he-were-20-today">Nvidia CEO Jensen Huang Says He&#8217;d Ditch Software For Physical Sciences If He Were 20 Today</a></li>
</ul>
Image Via Shutterstock

Tech

Mark Zuckerberg's Wife Priscilla Chan Reveals Her Secret Weapon To Lure Top Talent To CZI — And It's Not Eight-Figure Salaries Like Her Husband Offers At Meta

Wag! Initiates Chapter 11 Proceeding In Delaware Court As Part Of Recapitalization With Primary Lender Retriever

U.S. GoldMining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USGO#NASDAQ">USGO</a>) ("U.S. GoldMining" or the "Company") is&nbsp;pleased to provide an update on the Whistler Gold-Copper Project (the "Project") in Alaska, U.S.A. The Company is currently preparing and mobilizing for the 2025 field season which will focus on developing new potential porphyry gold-copper drill targets within the Whistler Orbit and undertaking follow-up mapping and sampling at the Muddy Creek prospect.
2025 Planned Exploration Program Highlights:
<ul>
<li>The 2025 exploration program expands the scope from previous seasons, which focused on delineating and growing the Whistler deposit. As the Company advances its previously announced initial assessment study ("PEA") for the Project (see news release dated June 9, 2025) with the objective of defining a potential economic base-case mining opportunity, the Company's exploration focus now turns to developing a pipeline of exploration targets at the district-scale, which aims to deliver additional future potential mineral resources over the longer term. &nbsp;</li>
<li>The focus of the planned 2025 exploration program (the "Program") is to develop new drill targets for potential gold-copper mineralization within the Whistler – Raintree mineral system, also referred to as the 'Whistler Orbit', which comprises a classic 'porphyry cluster' spread over an area of approximately 5 x 5 km, containing multiple mapped and interpreted porphyry intrusions and including the established Whistler and Raintree West mineral resource deposits. &nbsp;</li>
<li>The Program will also include follow-up mapping and sampling of the&nbsp;Muddy Creek mineral system – a large gold-in-soil geochemical footprint over an area of approximately 6 km x 4 km with an intrusion-related gold geochemical signature.&nbsp;</li>
</ul>

USGO

US GoldMining Expands 2025 Exploration in Alaska to Unlock New Gold-Copper Targets at Whistler Project

Linde Announces New Industrial Gas Investments In Florida And Texas To Support Expanding U.S. Space Sector

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4471431-1&amp;h=1680043096&amp;u=https%3A%2F%2Fwww.westpharma.com%2F&amp;a=West+Pharmaceutical+Services%2C+Inc.">West Pharmaceutical Services, Inc.</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WST#NYSE">WST</a>), a global leader in innovative solutions for injectable drug administration, today announced the appointment of Robert McMahon as the company's new Chief Financial Officer (CFO), effective August 4, 2025. Mr. McMahon will succeed&nbsp;Bernard Birkett, CFO, who announced his intention to retire earlier this year. Mr. Birkett will assume the role of Senior Advisor to the CEO through the end of the year to ensure a seamless transition. &nbsp;

Management

West Pharmaceutical Names Robert McMahon as New CFO, Succeeding Retiring Finance Chief Bernard Birkett

Shares of Block, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) rose sharply in pre-market trading ahead of the S&amp;P 500 debut of the Jack Dorsey-founded <a href="https://www.benzinga.com/quote/XYZ">fintech company</a>.
Block will replace Hess Corp. in the S&amp;P 500 effective prior to the opening of trading on Wednesday, July 23.
Block shares jumped 9.6% to $79.81 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>GlucoTrack, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCTK#NASDAQ">GCTK</a>) shares jumped 82% to $10.61 in pre-market trading.</li>
<li>Dynamix Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYNX#NASDAQ">DYNX</a>) surged 55.4% to $15.73 in pre-market trading. The Wall Street Journal reported Dynamix plans merger to form The Ether Machine.</li>
<li>TNF Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNFA#NASDAQ">TNFA</a>) shares gained 54% to $0.1347 in pre-market trading after declining around 8% on Friday.</li>
<li>Incannex Healthcare Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IXHL#NASDAQ">IXHL</a>) rose 42.2% to $0.8674 in pre-market trading after jumping 65% on Friday.</li>
<li>LM Funding America, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMFA#NASDAQ">LMFA</a>) gained 27.8% to $4.13 in pre-market trading after gaining more than 45% on Friday.</li>
<li>WANG &amp; LEE GROUP, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) climbed 27.3% to $0.0598 in pre-market trading after gaining 13% on Thursday.</li>
<li>180 Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) rose 18.1% to $2.22 in pre-market trading.</li>
<li>Solid Power, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDP#NASDAQ">SLDP</a>) surged 14.1% to $4.30 in pre-market trading after gaining 17% on Friday.</li>
<li>Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) surged 12.3% to $2.53 in pre-market trading after gaining 36% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Expion360 Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XPON#NASDAQ">XPON</a>) dipped 15.2% to $1.34 in pre-market trading after gaining 52% on Friday.</li>
<li>Telomir Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TELO#NASDAQ">TELO</a>) dipped 13.6% to $1.97 in pre-market trading. Telomir Pharmaceuticals shares jumped 88% on Friday after the company announced data for its gene silencing of STAT1.</li>
<li>Evotec SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NASDAQ">EVO</a>) declined 11.3% to $3.78 in pre-market trading after the company updated its revenue guidance for the fiscal year 2025.</li>
<li>Cyclacel Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYCC#NASDAQ">CYCC</a>) shares tumbled 10% to $11.77 in pre-market trading after jumping over 58% on Friday.</li>
<li>K-TECH Solutions Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KMRK#NASDAQ">KMRK</a>) fell 8.2% to $2.25 in pre-market trading after dipping 45% on Friday.</li>
<li>Majestic Ideal Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MJID#NASDAQ">MJID</a>) declined 7.9% to $3.04 in pre-market trading after dipping 45% on Friday.</li>
<li>Graphjet Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTI#NASDAQ">GTI</a>) fell 7.1% to $0.0798 in pre-market trading after declining around 9% on Friday.</li>
<li>Adicet Bio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACET#NASDAQ">ACET</a>) fell 7.1% to $0.7061 in pre-market trading after falling 4% on Friday.</li>
<li>Webull Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BULL#NASDAQ">BULL</a>) fell 6.4% to $15.79 in pre-market trading. Webull filed for up to 75.16 million share ordinary stock offering by selling shareholder.</li>
<li>SaverOne 2014 Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVRE#NASDAQ">SVRE</a>) shares fell 4% to $2.86 in pre-market trading after jumping 18% on Friday.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/07/46491269/top-2-energy-stocks-that-may-fall-off-a-cliff-this-quarter-2">Top 2 Energy Stocks That May Fall Off A Cliff This Quarter</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACET

ATNF

BULL

CYCC

GCTK

IXHL

KMRK

LMFA

MJID

OPEN

SLDP

SVRE

TELO

TNFA

WLGS

XPON

Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

Outlook
The Company updated previously guided expectations for the full-year 2025, as follows:
<ul>
<li>Capital expenditures of approximately $600 million, from its previous expectation of $625 million</li>
<li>Selling, general and administrative expenses of approximately $575 million, from its previous expectation of approximately $600 million</li>
<li>Steel unit cost reductions maintained at a reduction of approximately $50 per net ton compared to 2024</li>
<li>Depreciation, depletion and amortization of approximately $1.2 billion, from its previous expectation of approximately $1.1 billion, primarily due to accelerated depreciation from idled facilities</li>
<li>Cash Pension and OPEB payments and contributions maintained at approximately $150 million</li>
</ul>

Guidance

Cleveland-Cliffs Cuts 2025 Capex To $600M From $625M, Lowers SG&A To $575M From $600M, Hikes Depreciation To $1.2B From $1.1B

LexinFintech Holdings Ltd. ("Lexin" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>), a leading technology-empowered personal financial service enabler in China, today announced that its board of directors has authorized a share repurchase program under which the Company may purchase up to US$50 million of its shares over the next twelve months (the "Share Repurchase Program").
The Company's proposed repurchases may be made from time to time through open market transactions at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on the market conditions and in accordance with applicable rules and regulations. The timing and dollar amount of the repurchase transactions will be subject to the Securities and Exchange Commission Rule 10b-18 and/or Rule 10b5-1 requirements. The Company's board of directors will review the Share Repurchase Program periodically, and may authorize adjustments of its terms and size or suspend or discontinue the program.
In addition, Mr. Jay Wenjie Xiao, Chairman and Chief Executive Officer of Lexin, has informed the Company that he planned to use his personal funds to purchase the Company's American depository shares (the "ADSs"). Mr. Xiao intends to purchase up to US$10 million worth of the ADSs within the next twelve months, pursuant and subject to applicable laws and the Company's securities trading policy. Mr. Xiao makes his own independent decision on the share purchase and its terms. The share purchases by Mr. Xiao may be made from time to time in the open market at prevailing market prices, in privately negotiated transactions, in block trades and/or through other legally permissible means, depending on market conditions and in accordance with applicable rules and regulations.

Buybacks

LexinFintech Launches $50M Share Buyback Plan, CEO Jay Xiao to Personally Invest Up to $10M

<ul>
<li>Alixorexton Demonstrated Clinically Meaningful and Statistically Significant Improvements in Wakefulness at All Doses Tested Compared to Placebo in Patients With Narcolepsy Type 1.</li>
<li>Alixorexton Demonstrated Robust and Consistent Improvements in Patient-Reported Outcomes Related to Disease Severity, Fatigue and Cognition at All Doses Tested.</li>
<li>Alixorexton Was Generally Well Tolerated at All Doses Tested.</li>
<li>Detailed Results to Be Presented at Upcoming World Sleep Congress.</li>
<li>Data Support Advancement of&nbsp;Alixorexton to Phase 3 Development in Narcolepsy</li>
</ul>

Biotech

Health Care

General

ALKS

Alkermes Released Topline Results From Vibrance-1 Phase 2 Study Of Alixorexton For Narcolepsy Type 1, Meeting The Primary Endpoint Across All Doses Tested

JP Morgan analyst Rajat Gupta maintains Carvana (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) with a Overweight and raises the price target from $325 to $350.

CVNA

JP Morgan Maintains Overweight on Carvana, Raises Price Target to $350

Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of $(0.70) by 29.08 percent. This is a 554.55 percent decrease over earnings of $0.11 per share from the same period last year. The company reported quarterly sales of $4.93 billion which met the analyst consensus estimate. This is a 3.10 percent decrease over sales of $5.09 billion the same period last year.

Cleveland-Cliffs Q2 Adj. EPS $(0.50) Beats $(0.70) Estimate, Sales $4.93B Inline

Keefe, Bruyette &amp; Woods analyst Brady Gailey maintains Bank7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSVN#NASDAQ">BSVN</a>) with a Outperform and raises the price target from $47 to $52.

BSVN

Keefe, Bruyette & Woods Maintains Outperform on Bank7, Raises Price Target to $52

Press Releases

Vertical Aerospace Makes Aviation History with Piloted eVTOL Flight in Open Airspace

Vertical Aerospace Appoints Former MI5 Director General Lord Andrew Parker to Board

Vertical and Bristow Partner to Deliver Full Service 'Ready-to-Fly' eVTOL Operations for VX4 Customers

Vertical Aerospace Announces Date for AGM

Vertical Aerospace Expands Leadership Team With Key Executive Appointments

Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering

Vertical Aerospace Announces Pricing of Underwritten Public Offering

Vertical Aerospace Announces Closing of $60M Underwritten Public Offering

Vertical Aerospace to Report 2025 First Half Results on 5 August, 2025

Vertical Aerospace Completes World First Public Airport-to-Airport Flight

EVTL

VTOL

AIRO Group Holdings

AerSale

Astronics

Byrna Technologies

Cadre Hldgs

CPI Aerostructures

Ducommun

EHang Holdings

Eve Holding

New Horizon Aircraft Ltd. - Class A Ordinary Shares

New Horizon Aircraft

Innovative Solutions and Support, Inc. - Common Stock

Innovative Solns

Intuitive Machines, Inc. - Class A Common Stock

Intuitive Machines

National Presto Industries, Inc. Common Stock

National Presto Indus

Optex Systems Holdings, Inc. - Common Stock

Optex Systems Hldgs

Park Aerospace

Redwire

Satellogic

Sidus Space

Safe Pro Group

Virgin Galactic Holdings, Inc. Common Stock

Virgin Galactic Hldgs

Triumph Group

Voyager Technologies, Inc. Class A Common Stock

Voyager Technologies

VirTra

Needham

Canaccord Genuity

D. Boral Capital

HC Wainwright & Co.

Deutsche Bank

Comments

Vertical Aerospace

Vertical Aerospace (EVTL) Options

Vertical Aerospace (NYSE:EVTL) Stock, Chaîne d'Options

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL